应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02158 医渡科技
休市中 07-03 16:08:15
5.170
+0.300
+6.16%
最高
5.300
最低
4.910
成交量
1,355万
今开
4.910
昨收
4.870
日振幅
8.01%
总市值
52.73亿
流通市值
52.73亿
总股本
10.20亿
成交额
6,990万
换手率
1.33%
流通股本
10.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 医渡科技(02158.HK)再涨超5% 2026财年首次实现全年盈利 公司正式进入商业化兑现期
智通财经 · 07-03 13:39
港股异动 | 医渡科技(02158.HK)再涨超5% 2026财年首次实现全年盈利 公司正式进入商业化兑现期
医渡科技首次全年盈利,中试基地成AI医疗重要落地场景
第一财经 · 07-02 17:56
医渡科技首次全年盈利,中试基地成AI医疗重要落地场景
一图看懂医渡科技(02158)2026财年业绩:首次全年盈利!
智通财经 · 07-02
一图看懂医渡科技(02158)2026财年业绩:首次全年盈利!
港股异动 | 医渡科技(02158)涨超17% 2026财年扭亏为盈 经营现金流实现转正
智通财经 · 06-30
港股异动 | 医渡科技(02158)涨超17% 2026财年扭亏为盈 经营现金流实现转正
港股公告掘金 | 医渡科技发布年度业绩 股东应占利润7270.9万元 成功实现从亏损到盈利的历史性跨越
智通财经 · 06-30
港股公告掘金 | 医渡科技发布年度业绩 股东应占利润7270.9万元 成功实现从亏损到盈利的历史性跨越
医渡科技(02158.HK)将于9月16日派发末期股息每股0.04港元
智通财经 · 06-30
医渡科技(02158.HK)将于9月16日派发末期股息每股0.04港元
医渡科技(02158)发布年度业绩 股东应占利润7270.9万元 成功实现从亏损到盈利的历史性跨越
智通财经 · 06-30
医渡科技(02158)发布年度业绩 股东应占利润7270.9万元 成功实现从亏损到盈利的历史性跨越
医渡科技:2026财年净利润7876.60万元
南方财经网 · 06-30
医渡科技:2026财年净利润7876.60万元
医渡科技:9月16日将派发股息0.04港元/股
南方财经网 · 06-30
医渡科技:9月16日将派发股息0.04港元/股
医渡科技2026财年扭亏为盈 年度利润达7877万元
公告速递 · 06-30
医渡科技2026财年扭亏为盈 年度利润达7877万元
医渡科技建议派发末期股息每股0.04港元,待股东大会批准
公告速递 · 06-30
医渡科技建议派发末期股息每股0.04港元,待股东大会批准
医渡科技:年度业绩延迟发布 董事会会议推迟至6月30日
财中社 · 06-29
医渡科技:年度业绩延迟发布 董事会会议推迟至6月30日
医渡科技5月无新增发行或股份变动
公告速递 · 06-04
医渡科技5月无新增发行或股份变动
医渡科技(02158)拟4亿收购在线医生平台,花旗给予“买入”评级
智通财经 · 06-02
医渡科技(02158)拟4亿收购在线医生平台,花旗给予“买入”评级
4亿买下350万‘执医’! 医渡科技(02158)补齐最后一块拼图,一场估值逻辑的暴力切换正在发生
智通财经 · 06-02
4亿买下350万‘执医’! 医渡科技(02158)补齐最后一块拼图,一场估值逻辑的暴力切换正在发生
港股午评|恒生指数早盘涨0.87% SaaS概念股全线大涨
智通财经 · 06-01
港股午评|恒生指数早盘涨0.87% SaaS概念股全线大涨
港股公告掘金 | 至源控股订立15万吨锂辉石矿购买协议及加工协议 助力AI基础设施相关业务落地
智通财经 · 06-01
港股公告掘金 | 至源控股订立15万吨锂辉石矿购买协议及加工协议 助力AI基础设施相关业务落地
医渡科技(02158)拟4亿元收购一家主要从事线上医生平台的运营及相关服务业务的公司
智通财经 · 06-01
医渡科技(02158)拟4亿元收购一家主要从事线上医生平台的运营及相关服务业务的公司
医渡科技拟收购在线医生平台公司全部股权 签署谅解备忘录
美股速递 · 06-01
医渡科技拟收购在线医生平台公司全部股权 签署谅解备忘录
异动解读 | 北京市委书记调研勉励,医渡科技盘中大涨5.09%
异动解读 · 05-22
异动解读 | 北京市委书记调研勉励,医渡科技盘中大涨5.09%
加载更多
公司概况
公司名称:
医渡科技
所属市场:
SEHK
上市日期:
--
主营业务:
医渡科技有限公司是一家主要从事提供基于大数据和人工智能(AI)技术的医疗解决方案的投资控股公司。该公司主要通过三个分部运营其业务。大数据平台和解决方案分部从事提供数据智能平台及数据分析驱动的解决方案。生命科学解决方案分部从事为药物和医疗器械的全生命周期管理提供支持,涵盖从临床开发到上市后的各个阶段。健康管理平台和解决方案分部从事提供AI赋能的健康管理解决方案。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02158","market":"HK","secType":"STK","nameCN":"医渡科技","latestPrice":5.17,"timestamp":1783066095004,"preClose":4.87,"halted":0,"volume":13554548,"delay":0,"changeRate":0.06160164271047224,"floatShares":1019999999,"shares":1019999999,"eps":0.0801522907236713,"marketStatus":"休市中","change":0.3,"latestTime":"07-03 16:08:15","open":4.91,"high":5.3,"low":4.91,"amount":69900121,"amplitude":0.080082,"askPrice":5.18,"askSize":5400,"bidPrice":5.17,"bidSize":5400,"shortable":3,"etf":0,"ttmEps":0.0801522907236713,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":7,"adr":0,"listingDate":1610640000000,"exchange":"SEHK","adjPreClose":4.87,"openAndCloseTimeList":[[1783042200000,1783051200000],[1783054800000,1783065600000]],"volumeRatio":0.8614797134242222,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02158","defaultTab":"news","newsList":[{"id":"2648653046","title":"港股异动 | 医渡科技(02158.HK)再涨超5% 2026财年首次实现全年盈利 公司正式进入商业化兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2648653046","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648653046?lang=zh_cn&edition=full","pubTime":"2026-07-03 13:39","pubTimestamp":1783057175,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1617","BK1518","02158","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648587509","title":"医渡科技首次全年盈利,中试基地成AI医疗重要落地场景","url":"https://stock-news.laohu8.com/highlight/detail?id=2648587509","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648587509?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:56","pubTimestamp":1782986173,"startTime":"0","endTime":"0","summary":"7月2日,国内头部AI医疗公司医渡科技(02158.HK)召开2026财年业绩发布会后,公司盘中股价一度上涨超7%。截至收盘,医渡科技股价上涨近5%。医渡科技当天对截至2026年3月31日止(2026财年)的年度业绩报告进行了解读。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607023792020514.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607023792020514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1518","AGIX","02158","AIPO","ARTY","BK1189","159891","BK1617","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648575502","title":"一图看懂医渡科技(02158)2026财年业绩:首次全年盈利!","url":"https://stock-news.laohu8.com/highlight/detail?id=2648575502","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648575502?lang=zh_cn&edition=full","pubTime":"2026-07-02 11:04","pubTimestamp":1782961456,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,7月2日,中国AI医疗头部企业医渡科技召开2026财年业绩发布会,对其截至2026年3月31日止的年度业绩报告进行解读。报告期内,公司首次实现全年盈利,年度利润达人民币7876.6万元,超出此前5500万至7000万元的盈利预告净利润区间上限;归母净利润达人民币7270.9万元,较预告对应的归母净利润区间上限5600万元高出约30%。公司全年总收入同比增长14.6%达8.2亿元,经调整EBITDA同比增长超4.6倍至人民币2.2亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"一图看懂医渡科技(02158)2026财年业绩:首次全年盈利!","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","BK1617","BK1189","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647858635","title":"港股异动 | 医渡科技(02158)涨超17% 2026财年扭亏为盈 经营现金流实现转正","url":"https://stock-news.laohu8.com/highlight/detail?id=2647858635","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647858635?lang=zh_cn&edition=full","pubTime":"2026-06-30 09:46","pubTimestamp":1782783964,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,医渡科技盘中涨超17%,截至发稿,涨15.37%,报5.03港元,成交额5251.57万港元。消息面上,医渡科技今早发布截至2026年3月31日止财政年度业绩,公司迎来发展里程碑,首度实现年度盈利。报告期内,公司取得收入8.19亿元,同比增加14.6%;公司拥有人应占利润7270.9万元,同比扭亏为盈;下半年经营活动现金流净额实现转正,取得人民币2930万元。公司拟派付末期股息每股0.04港元。公司三大主营业务板块均保持稳健增长,协同构筑业绩基本盘。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK1518","02158","BK1617","BK1189","BK4585","159399","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647585848","title":"港股公告掘金 | 医渡科技发布年度业绩 股东应占利润7270.9万元 成功实现从亏损到盈利的历史性跨越","url":"https://stock-news.laohu8.com/highlight/detail?id=2647585848","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647585848?lang=zh_cn&edition=full","pubTime":"2026-06-30 09:07","pubTimestamp":1782781645,"startTime":"0","endTime":"0","summary":"重大事项:宝济药业-B(02659):BJ044注射液(重组乌司他丁)临床试验申请获得国家药监局批准广和通(00638)拟14.28亿元收购航盛电子37.16%股权 实现“通信模组+汽车电子系统”的软硬件垂直整合晋景新能(01783)拟最高25亿港元收购YV CLOUD Limited及上海有孚云全部股权 布局 IDC 及 AI 算力业务佑驾创新(02431):全场景物理AI合资公司完成注册设立I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01783","BK1518","BK1148","02659","00638","BK1189","BK4585","BK1144","BK4588","VXUS","BK1617","BK1161","02158","BK1149","BK1214","02431"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647634583","title":"医渡科技(02158.HK)将于9月16日派发末期股息每股0.04港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647634583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647634583?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:27","pubTimestamp":1782779249,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1518","BK1617","BK1189","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588272","title":"医渡科技(02158)发布年度业绩 股东应占利润7270.9万元 成功实现从亏损到盈利的历史性跨越","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588272","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647588272?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:07","pubTimestamp":1782778075,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技 发布截至2026年3月31日止财政年度业绩,该集团期内取得收入8.19亿元,同比增加14.6%;公司拥有人应占利润7270.9万元,同比扭亏为盈;每股基本盈利0.07元;拟派付末期股息每股0.04港元。集团始终坚持聚焦战略,深耕核心客户与关键业务,报告期内成功实现从亏损到盈利的历史性跨越。截至2026年3月31日,集团总收入达到人民币8.19亿元,同比增长14.6%,毛利率从33.5%提升至36.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1617","02158","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647886665","title":"医渡科技:2026财年净利润7876.60万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647886665","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647886665?lang=zh_cn&edition=full","pubTime":"2026-06-30 07:23","pubTimestamp":1782775380,"startTime":"0","endTime":"0","summary":"南财智讯6月30日电,医渡科技(02158.HK)公告,截至2026年3月31日止财年,公司总收入为人民币8.19亿元,同比增长14.6%;年内溢利为人民币7876.60万元;每股基本盈利为0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303787127616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588366","title":"医渡科技:9月16日将派发股息0.04港元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588366","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647588366?lang=zh_cn&edition=full","pubTime":"2026-06-30 07:23","pubTimestamp":1782775380,"startTime":"0","endTime":"0","summary":"南财智讯6月30日电,医渡科技(02158.HK)公告,公司将于2026年9月16日派发截至2026年3月31日止年度的末期股息,每股派发0.04港元。除净日为2026年9月1日,记录日期为2026年9月7日,股份过户登记处暂停办理过户手续时间为2026年9月3日至9月7日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303787127758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1617","BK1518","EWH","02158","BK4588","BK1189","BK4585","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149745302","title":"医渡科技2026财年扭亏为盈 年度利润达7877万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149745302","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149745302?lang=zh_cn&edition=full","pubTime":"2026-06-30 06:38","pubTimestamp":1782772700,"startTime":"0","endTime":"0","summary":"医渡科技于截至2026年3月31日的财年内实现总收入人民币8.193亿元,同比增长14.6%,毛利录得人民币2.985亿元,增长24.8%,毛利率从2025财年的33.5%提升至36.4%。经营利润达到人民币8783万元,相较上年度亏损人民币1.341亿元显著改善;全年实现年度利润人民币7877万元,而上一财年则录得亏损人民币1.352亿元。归属于母公司拥有人应占利润为人民币7271万元,上年同期为亏损人民币1.178亿元。截至2026年3月31日,集团雇员总数为754名,薪酬成本合计人民币2.998亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"医渡科技2026财年扭亏为盈 年度利润达7877万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101633169","title":"医渡科技建议派发末期股息每股0.04港元,待股东大会批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1101633169","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101633169?lang=zh_cn&edition=full","pubTime":"2026-06-30 06:35","pubTimestamp":1782772554,"startTime":"0","endTime":"0","summary":"医渡科技(02158)发布公告,建议派发截至2026年3月31日止年度的末期股息,每股0.04港元。该派息方案尚需提交于2026年8月28日召开的股东周年大会审议批准。\n根据公告,该股息的除净日为2026年9月1日,为符合获取股息分派而递交股份过户文件的最后时限为2026年9月2日16:30。公司将于2026年9月3日至9月7日暂停办理股份过户登记手续,股权登记日定于2026年9月7日。如获股东大会通过,股息将于2026年9月16日派发。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"医渡科技建议派发末期股息每股0.04港元,待股东大会批准","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647341141","title":"医渡科技:年度业绩延迟发布 董事会会议推迟至6月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2647341141","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647341141?lang=zh_cn&edition=full","pubTime":"2026-06-29 08:41","pubTimestamp":1782693660,"startTime":"0","endTime":"0","summary":"6月29日,医渡科技(02158)发布公告,因审计委员会于2026年6月22日接获关于一名员工行为的资料,导致截至2026年3月31日止年度的年度业绩公告延迟。虽然审计委员会在独立法证专家的协助下已完成对该事项的评估,并未发现任何实质性问题,但公司仍在积极配合核数师完成审计工作。因此,原定于2026年6月28日举行的董事会会议将延期至2026年6月30日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293785683960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1617","BK1189","02158","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126228094","title":"医渡科技5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1126228094","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126228094?lang=zh_cn&edition=full","pubTime":"2026-06-04 18:02","pubTimestamp":1780567350,"startTime":"0","endTime":"0","summary":"医渡科技有限公司于2026年6月4日发布2026年5月股份变动月报表,报告期为截至2026年5月31日。本月无新增发行股份、无购回及无注销记录。根据公告,医渡科技目前设有多个购股权计划及激励安排。截至2026年5月末,“首次公开发售后购股权计划”持有购股权5,827,573份,“首次公开发售前购股权计划1”持有购股权1,652,650份,“首次公开发售前购股权计划2”持有购股权15,923,004份,均无当月变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640999172","title":"医渡科技(02158)拟4亿收购在线医生平台,花旗给予“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2640999172","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640999172?lang=zh_cn&edition=full","pubTime":"2026-06-02 11:48","pubTimestamp":1780372092,"startTime":"0","endTime":"0","summary":"公司于6月1日发布自愿性公告,宣布拟斥资约4亿元人民币收购一家头部在线医生平台的100%股权。此举迅速引发资本市场关注,国际大行花旗随即发布研报,给予该公司“买入”评级,目标价定为11港元。医渡科技认为,此次收购一旦落实,将实现技术与场景的“强强联合”。花旗据此给予医渡科技 “买入”评级,目标价11港元。截至发稿,医渡科技市值维持在55亿港元左右,随着此次收购的推进及AI产品的持续落地,市场关注度有望不断升温。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640180996","title":"4亿买下350万‘执医’! 医渡科技(02158)补齐最后一块拼图,一场估值逻辑的暴力切换正在发生","url":"https://stock-news.laohu8.com/highlight/detail?id=2640180996","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640180996?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:57","pubTimestamp":1780365452,"startTime":"0","endTime":"0","summary":"6月1日,医渡科技发布自愿性公告称,公司与一名独立第三方订立不具法律约束力的谅解备忘录,拟以约人民币4亿元收购一家主要从事在线医生平台运营及相关服务业务公司的100%股权。截至2026年3月31日,该平台累计注册用户约1100万人,其中约350万人为执业医生用户。医渡科技此次掏出的4亿元,买下的不仅是1.67亿收入和约5300万利润,更是约近350万名医生的信任入口,以及一张通往千亿级数字医疗市场的通行证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1518","BK1617","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640980247","title":"港股午评|恒生指数早盘涨0.87% SaaS概念股全线大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2640980247","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640980247?lang=zh_cn&edition=full","pubTime":"2026-06-01 12:01","pubTimestamp":1780286477,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数涨0.87%,涨218点,报25400点;恒生科技指数涨1.8%。港股早盘成交1952亿港元。美股软件板块业绩证伪AI吞噬叙事,估值修复弹性全面释放。煤炭股多数走高。南方区域用电负荷连续四日创历史新高,沿海现货电价明显上涨。全球集装箱海运价格飙升。博泰车联涨7.85%,携手英伟达布局未来智能出行,AI Box走向商业化落地。硬蛋创新再涨14.2%,AI基建竞赛已转向系统效能优化,公司订单充足且经营向好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["82800","BK1589","BK1616","BK1178","00316","07300","HHImain","BK1103","BK1233","07552","00354","02013","00902","BK1590","03032","601898","BK1516","HSTECH","BK1517","LU1048588211.SGD","OROVY","02097","03067","09088","09067","KGDEY","07200","LU0456827905.SGD","CCOZY","600011","SG9999014674.SGD","83115","03115","IE0034224299.USD","BK1505","BK1155","00136","01171","03037","00400","BK1594","03419","BK1142","01898","600027","BK1109","BK1598","00894","01138","02837","09115","BK1526","BK1617","02889","00596","MCHmain","LU0072462343.USD","BK1518","BK1125","BK1613","BK1538","BK1500","BK1535","03088","BK1128","02833","07226","00268","SG9999001440.SGD","601919","03033","BK1530","02800","01919","BK1587","BK1607","600026","BK1166","BK1189","01071","03417","513600","BK1610","YZCAY","02158","07500","LU0051755006.USD","BK1586","HSI","BK1170","BK1144","600188","02556","BK1618","03423","BK1162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640843609","title":"港股公告掘金 | 至源控股订立15万吨锂辉石矿购买协议及加工协议 助力AI基础设施相关业务落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2640843609","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640843609?lang=zh_cn&edition=full","pubTime":"2026-06-01 09:06","pubTimestamp":1780276011,"startTime":"0","endTime":"0","summary":"重大事项:信达生物(01801)与辉瑞达成全球战略合作 加速创新肿瘤药物开发复宏汉霖(02696)自主研发的汉倍优于中国境内获批上市东瑞制药(02348):盐酸曲唑酮片50毫克及100毫克获得药品生产注册批件石药集团(01093):恩尼妥(安尼妥单抗注射液)获国家药监局批准上市中国生物制药(01177):纳地美定“外周μ-阿片受体拮抗剂”获批上市博泰车联(02889)与NVIDIA在美国举行战略合","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448264.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1144","BK1240","BK1617","BK4585","BK1518","BK1200","VXUS","BK1189","00990","00199","AIPO","BK1124","02431","BK4588","02158","01115","02889"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640398149","title":"医渡科技(02158)拟4亿元收购一家主要从事线上医生平台的运营及相关服务业务的公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2640398149","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640398149?lang=zh_cn&edition=full","pubTime":"2026-06-01 08:46","pubTimestamp":1780274802,"startTime":"0","endTime":"0","summary":"智通财经APP讯,医渡科技 发布公告,于2026年5月29日,公司与一名独立第三方就建议收购一家主要从事线上医生平台的运营及相关服务业务的公司100%股权订立一份不具法律约束力的谅解备忘录。建议收购完成后,医渡科技通过其指定代名人或附属公司将持有目标公司100%的股权,而目标公司将并入医渡科技的财务报表。目标公司主要从事线上医生平台的运营及相关服务业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","02158","BK1189","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169406548","title":"医渡科技拟收购在线医生平台公司全部股权 签署谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=1169406548","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169406548?lang=zh_cn&edition=full","pubTime":"2026-06-01 08:21","pubTimestamp":1780273271,"startTime":"0","endTime":"0","summary":"医渡科技于5月29日宣布,已就一项拟议收购案签署谅解备忘录,计划收购一家从事在线医生平台业务公司的全部股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","BK1617","02158","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136532001","title":"异动解读 | 北京市委书记调研勉励,医渡科技盘中大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136532001","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136532001?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:00","pubTimestamp":1779436841,"startTime":"0","endTime":"0","summary":"医渡科技今日盘中股价大幅拉升,涨幅达到5.09%,市场关注度显著提升。消息面上,北京市委书记尹力于近期围绕“数智赋能健康北京建设”主题,对医渡科技进行了实地调研。尹力书记在调研中强调,要强化数据赋能科技创新,深挖数据价值推动产业高质量发展,并完善数据合规管理体系。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1697},{"period":"1month","weight":-0.03},{"period":"3month","weight":0.0098},{"period":"6month","weight":-0.0336},{"period":"1year","weight":-0.093},{"period":"ytd","weight":-0.0152}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医渡科技有限公司是一家主要从事提供基于大数据和人工智能(AI)技术的医疗解决方案的投资控股公司。该公司主要通过三个分部运营其业务。大数据平台和解决方案分部从事提供数据智能平台及数据分析驱动的解决方案。生命科学解决方案分部从事为药物和医疗器械的全生命周期管理提供支持,涵盖从临床开发到上市后的各个阶段。健康管理平台和解决方案分部从事提供AI赋能的健康管理解决方案。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.077386},{"month":2,"riseRate":0.666667,"avgChangeRate":0.095773},{"month":3,"riseRate":0,"avgChangeRate":-0.131056},{"month":4,"riseRate":0.5,"avgChangeRate":0.012812},{"month":5,"riseRate":0,"avgChangeRate":-0.076986},{"month":6,"riseRate":0.5,"avgChangeRate":0.037194},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.027671},{"month":8,"riseRate":0.2,"avgChangeRate":-0.107097},{"month":9,"riseRate":0.6,"avgChangeRate":-0.067899},{"month":10,"riseRate":0.2,"avgChangeRate":-0.069507},{"month":11,"riseRate":0.6,"avgChangeRate":0.153719},{"month":12,"riseRate":0.6,"avgChangeRate":0.017309}],"exchange":"SEHK","name":"医渡科技","nameEN":"YIDU TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医渡科技,02158,医渡科技股票,医渡科技股票老虎,医渡科技股票老虎国际,医渡科技行情,医渡科技股票行情,医渡科技股价,医渡科技股市,医渡科技股票价格,医渡科技股票交易,医渡科技股票购买,医渡科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}